Servicio de Medicina Intensiva, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
Universitat Autònoma de Barcelona, Barcelona, Spain.
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.01825-17. Print 2018 Apr.
We evaluated the use of antimicrobials expressed as defined daily doses (DDDs) per 1,000 patient days and days of therapy (DOT) per 100 occupied bed-days in a intensive care unit (ICU) of a general hospital in Barcelona, Spain, before and after implementation of an antimicrobial stewardship (AMS) program (2007 to 2010 versus 2011 to 2015). The quarterly costs of antimicrobials used in the ICU and its weight in the overall hospital costs of antimicrobials were calculated. The effect of the applied AMS program on DDDs and DOT time series data was analyzed by means of intervention time series analysis. A total of 5,002 patients were included (1,971 for the first [before] period and 3,031 for the second [after] period). The percentage of patients treated with one or more antimicrobials decreased from 88.6 to 77.2% ( < 0.001). DDDs decreased from 246.8 to 192.3 (mean difference, -54.5; = 0.001) and DOT from 66.7 to 54.6 (mean difference, -12.1; = 0.066). The mean cost per trimester decreased from €115,543 to €73,477 (mean difference, -42,065.4 euros; < 0.001), and the percentage of ICU antimicrobials cost with respect to the total cost of hospital antimicrobials decreased from 28.5 to 22.8% (mean difference, -5.59; = 0.023). Implementation of an AMS program in the ICU was associated with a marked reduction in the use of antimicrobials, with cost savings close to one million euros since its implementation. An AMS program can have a significant impact on optimizing antimicrobial use in critical care practice.
我们评估了西班牙巴塞罗那一家综合医院重症监护病房(ICU)在实施抗菌药物管理(AMS)计划前后(2007 年至 2010 年与 2011 年至 2015 年)每千患者日的抗菌药物限定日剂量(DDD)和每 100 张占用病床日的治疗日(DOT)的使用情况。计算了 ICU 使用的抗菌药物的季度成本及其在医院总抗菌药物成本中的权重。通过干预时间序列分析,分析了应用 AMS 方案对 DDD 和 DOT 时间序列数据的影响。共纳入 5002 例患者(第 1 期[前]1971 例,第 2 期[后]3031 例)。接受一种或多种抗菌药物治疗的患者比例从 88.6%降至 77.2%(<0.001)。DDD 从 246.8 降至 192.3(平均差异,-54.5;=0.001),DOT 从 66.7 降至 54.6(平均差异,-12.1;=0.066)。每个季度的平均成本从 115543 欧元降至 73477 欧元(平均差异,-42065.4 欧元;<0.001),ICU 抗菌药物成本占医院抗菌药物总成本的比例从 28.5%降至 22.8%(平均差异,-5.59;=0.023)。在 ICU 实施 AMS 方案与抗菌药物使用量明显减少有关,自实施以来,节省成本接近 100 万欧元。AMS 方案可对抗菌药物在重症监护实践中的优化使用产生重大影响。